NCT00000698View on ClinicalTrials.gov

A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Study Completion Date

August 31, 2007

Conditions

Cytomegalovirus RetinitisHIV Infections

Interventions

DRUG

Ganciclovir

Trial Locations (1)

20892

Natl Inst of Allergy & Infect Dis / Cln Ctr, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000698 - A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis | Biotech Hunter | Biotech Hunter